Literature DB >> 3817400

Vibrio vulnificus infection after raw oyster ingestion in a patient with liver disease and acquired immune deficiency syndrome-related complex.

K P Chin, M A Lowe, M J Tong, A L Koehler.   

Abstract

Sepsis, peritonitis, and gastroenteritis developed in a 45-yr-old homosexual man 1 day after ingestion of raw oysters. The patient had chronic active hepatitis and cirrhosis with hepatitis B virus and delta-infection. He also had persistent generalized lymphadenopathy associated with HTLV-III antibody positivity. Vibrio vulnificus was isolated from the patient's blood and peritoneal fluid as well as from the same batch of oysters at the restaurant where the patient had visited. To our knowledge, this is the first report relating direct microbiologic and clinical evidence that the infection is acquired through the gastrointestinal tract by consuming raw seafood containing the pathogen. This is also the first reported case of peritonitis associated with sepsis and gastroenteritis from this organism. Patients with liver disease and other immunocompromised states should be warned about such life-threatening infections and complications associated with the consumption of raw oysters or other undercooked seafoods.

Entities:  

Mesh:

Year:  1987        PMID: 3817400     DOI: 10.1016/0016-5085(87)90035-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  The human pathogenic vibrios--a public health update with environmental perspectives.

Authors:  P A West
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

Review 2.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

3.  Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.

Authors:  S J Devi; U Hayat; J L Powell; J G Morris
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Detection of piluslike structures on clinical and environmental isolates of Vibrio vulnificus.

Authors:  R M Gander; M T LaRocco
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 5.  Vibrio vulnificus. Hazard on the half shell.

Authors:  K L Koenig; J Mueller; T Rose
Journal:  West J Med       Date:  1991-10

6.  Rhabdomyolysis induced by Pseudomonas aeruginosa sepsis.

Authors:  Naoya Iguchi; Yuji Fujino; Akinori Uchiyama; Osamu Hirao; Noriyuki Ohta; Takashi Mashimo; Eiichi Morii
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

7.  Preventing secondary infections among HIV-positive persons.

Authors:  G A Filice; C Pomeroy
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792

8.  A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction.

Authors:  N J Espat; T Auffenberg; A Abouhamze; J Baumhofer; L L Moldawer; R J Howard
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

9.  Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model.

Authors:  S J Devi; U Hayat; C E Frasch; A S Kreger; J G Morris
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.